ResearcherCentro de Investigación y de Estudios Avanzados del Instituto Politécnico NacionalActive in the last 2 years
Miguel Angel Vargas
Matched on ORCID iD 0000-0002-3031-9798; OpenAlex author ID A5088458670. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 9
2018: 1 paper · 2019: none · 2020: none · 2021: 2 papers · 2022: none · 2023: 2 papers · 2024: none · 2025: 1 paper
Papers 6
- MicroRNAs Let-7b-5p and miR-24-3p as Potential Therapeutic Agents Targeting Pancreatic Cancer Stem Cells. Co-author DOI 10.3390/ijms262211066↗
- Synergistic effect of antagonists to KRas4B/PDE6 molecular complex in pancreatic cancer. Last author DOI 10.26508/lsa.202302019↗
- Circulating miRNAs as Noninvasive Biomarkers for PDAC Diagnosis and Prognosis in Mexico. Co-author DOI 10.3390/ijms242015193↗
- H2A.Z overexpression suppresses senescence and chemosensitivity in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41388-021-01664-1↗
- Development of 177Lu-DN(C19)-CXCR4 Ligand Nanosystem for Combinatorial Therapy in Pancreatic Cancer. Co-author DOI 10.1166/jbn.2021.3016↗
- KRas4B-PDE6δ complex stabilization by small molecules obtained by virtual screening affects Ras signaling in pancreatic cancer. Last author DOI 10.1186/s12885-018-5142-7↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Rosaura Hernández‐Rivas · 5 shared papers, 2018–2025 · strength 0.69
- Paper MicroRNAs Let-7b-5p and miR-24-3p as Potential Therapeutic Agents Targeting Pancreatic Cancer Stem Cells. DOI 10.3390/ijms262211066↗
- Paper Circulating miRNAs as Noninvasive Biomarkers for PDAC Diagnosis and Prognosis in Mexico. DOI 10.3390/ijms242015193↗
- Paper Synergistic effect of antagonists to KRas4B/PDE6 molecular complex in pancreatic cancer. DOI 10.26508/lsa.202302019↗
- Paola Briseño-Díaz · 3 shared papers, 2018–2025 · strength 0.42
- Paper MicroRNAs Let-7b-5p and miR-24-3p as Potential Therapeutic Agents Targeting Pancreatic Cancer Stem Cells. DOI 10.3390/ijms262211066↗
- Paper Synergistic effect of antagonists to KRas4B/PDE6 molecular complex in pancreatic cancer. DOI 10.26508/lsa.202302019↗
- Paper KRas4B-PDE6δ complex stabilization by small molecules obtained by virtual screening affects Ras signaling in pancreatic… DOI 10.1186/s12885-018-5142-7↗
- Lissuly Guadalupe Álvarez-Hilario · 2 shared papers, 2021–2023 · strength 0.27
- Pedro Antonio Ávila-López · 2 shared papers, 2021–2023 · strength 0.27
- Maricela Medrano-Silva · 1 shared paper, 2025 · strength 0.21
- José Correa‐Basurto · 2 shared papers, 2018–2023 · strength 0.21
- Maydelid Trujillo-Nolasco · 1 shared paper, 2021 · strength 0.14
- Blanca Ocampo‐García · 1 shared paper, 2021 · strength 0.14
- Diana Casique‐Aguirre · 1 shared paper, 2018 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.